Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Merck Sharp & Dohme Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (146)
Australian public assessment report (AusPar) (4)

Date

2018 (1)
2017 (13)
2016 (38)
2015 (87)
2014 (11)

Search

Sponsor content

150 result(s) found, displaying 51 to 60

TAPTIQOM 15/5 tafluprost 15 microgram/mL and timolol (as maleate) 5 mg/mL single dose eye drop solution ampoule Cancelled under s30(1)

29 August 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
AusPAR: Ceftolozane (as sulfate) / Tazobactam (as sodium salt)

15 February 2016

Australian public assessment report (AusPar)

Australian Public Assessment Report
PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 50 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 80 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 100 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 120 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEG-INTRON REDIPEN INJECTOR peginterferon alfa-2b (rbe) 150 microgram powder for injection and diluent in dual-chamber cartridge Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEGATRON COMBINATION THERAPY peginterferon alfa-2b (rbe) 50 microgram powder for injection/capsule/diluent composite pack Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEGATRON COMBINATION THERAPY peginterferon alfa-2b (rbe) 80 microgram powder for injection/capsule/diluent composite pack Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
PEGATRON COMBINATION THERAPY peginterferon alfa-2b (rbe) 100 microgram powder for injection/capsule/diluent composite pack Cancelled under s30(1)(c) of the Act

4 December 2015

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.